MedPath

Effect of sertraline and melatonin on tinnitus

Phase 2
Completed
Conditions
Tinnitus.
Tinnitus
Registration Number
IRCT2017011412782N13
Lead Sponsor
Vice chancellor for research,Isfahan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
70
Inclusion Criteria

tinnitus for at least 6 months; normal audiogram test; possibility of follow up; Insensitivity to sertraline, melatonin and benzodiazepine compounds and agreement to participate in this study.
Exclusion criteria: patients who have tinnitus with specific etiology or have a history of recent head trauma.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.